Literature DB >> 19159058

White matter spectroscopy in neuromyelitis optica: a case control study.

Denis Bernardi Bichuetti1, René Leandro Magalhães Rivero, Enedina Maria Lobato de Oliveira, Daniel May Oliveira, Nilton Amorin de Souza, Roberto Gomes Nogueira, Nitamar Abdala, Alberto Gabbai.   

Abstract

BACKGROUND: Naa/Cr ratio in normal appearing white matter (NAWM) of patients with multiple sclerosis (MS) is altered beyond plaques, suggesting early axonal loss, and correlates to clinical disability. Brain lesions not typical of MS have been described in Neuromyelitis optica (NMO), and correspond to brain aquaporin-4 channel sites, but the evaluation of Naa/Cr ratio in NAWM of patients with NMO and its association to the presence of brain lesions and clinical disability have not been described.
OBJECTIVES: To evaluate the Naa/Cr of normal appearing white matter (NAWM) in 16 patients with NMO compared to healthy controls.
METHODS: We performed brain magnetic resonance imaging (MRI) and magnetic resonance spectroscopy (MRS) of 16 patients with NMO and compared to age matched healthy controls.
RESULTS: NAWM Naa/Cr did not show statistical difference among patients and controls, neither between patients that had normal brain MRI and atypical brain lesions.
CONCLUSION: NAWM was found to have a normal Naa/Cr in patients with NMO, reinforcing the concept that the white matter is not primarily affected in this disease.

Entities:  

Mesh:

Year:  2009        PMID: 19159058     DOI: 10.1007/s00415-009-0940-0

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  19 in total

1.  Absolute quantification of brain metabolites by proton magnetic resonance spectroscopy in normal-appearing white matter of multiple sclerosis patients.

Authors:  P Sarchielli; O Presciutti; G P Pelliccioli; R Tarducci; G Gobbi; P Chiarini; A Alberti; F Vicinanza; V Gallai
Journal:  Brain       Date:  1999-03       Impact factor: 13.501

2.  A secondary progressive clinical course is uncommon in neuromyelitis optica.

Authors:  D M Wingerchuk; S J Pittock; C F Lucchinetti; V A Lennon; B G Weinshenker
Journal:  Neurology       Date:  2007-02-20       Impact factor: 9.910

3.  Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination.

Authors:  C Lucchinetti; W Brück; J Parisi; B Scheithauer; M Rodriguez; H Lassmann
Journal:  Ann Neurol       Date:  2000-06       Impact factor: 10.422

4.  Neuromyelitis optica brain lesions localized at sites of high aquaporin 4 expression.

Authors:  Sean J Pittock; Brian G Weinshenker; Claudia F Lucchinetti; Dean M Wingerchuk; John R Corboy; Vanda A Lennon
Journal:  Arch Neurol       Date:  2006-07

Review 5.  N-acetyl-L-aspartic acid: a literature review of a compound prominent in 1H-NMR spectroscopic studies of brain.

Authors:  D L Birken; W H Oldendorf
Journal:  Neurosci Biobehav Rev       Date:  1989       Impact factor: 8.989

6.  Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis.

Authors:  F D Lublin; S C Reingold
Journal:  Neurology       Date:  1996-04       Impact factor: 9.910

7.  Revised diagnostic criteria for neuromyelitis optica.

Authors:  D M Wingerchuk; V A Lennon; S J Pittock; C F Lucchinetti; B G Weinshenker
Journal:  Neurology       Date:  2006-05-23       Impact factor: 9.910

8.  Brain abnormalities in neuromyelitis optica.

Authors:  Sean J Pittock; Vanda A Lennon; Karl Krecke; Dean M Wingerchuk; Claudia F Lucchinetti; Brian G Weinshenker
Journal:  Arch Neurol       Date:  2006-03

9.  Devic's neuromyelitis optica: a clinicopathological study of 8 patients.

Authors:  R N Mandler; L E Davis; D R Jeffery; M Kornfeld
Journal:  Ann Neurol       Date:  1993-08       Impact factor: 10.422

10.  IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel.

Authors:  Vanda A Lennon; Thomas J Kryzer; Sean J Pittock; A S Verkman; Shannon R Hinson
Journal:  J Exp Med       Date:  2005-08-08       Impact factor: 14.307

View more
  11 in total

Review 1.  Brain MRI in neuromyelitis optica: what is its role?

Authors:  Wei Qiu; Allan G Kermode
Journal:  Curr Neurol Neurosci Rep       Date:  2011-12       Impact factor: 5.081

2.  Neuromyelitis optica - an update: 2007-2009.

Authors:  Anu Jacob
Journal:  Ann Indian Acad Neurol       Date:  2009-10       Impact factor: 1.383

3.  Longitudinal ultra-high field MRI of brain lesions in neuromyelitis optica spectrum disorders.

Authors:  Sanjeev Chawla; Yulin Ge; Jens Wuerfel; Shadi Asadollahi; Suyash Mohan; Friedemann Paul; Tim Sinnecker; Ilya Kister
Journal:  Mult Scler Relat Disord       Date:  2020-03-25       Impact factor: 4.339

4.  Brain parenchymal damage in neuromyelitis optica spectrum disorder - A multimodal MRI study.

Authors:  F Pache; H Zimmermann; C Finke; A Lacheta; S Papazoglou; J Kuchling; J Wuerfel; B Hamm; K Ruprecht; F Paul; A U Brandt; M Scheel
Journal:  Eur Radiol       Date:  2016-03-24       Impact factor: 5.315

Review 5.  Use of Advanced Magnetic Resonance Imaging Techniques in Neuromyelitis Optica Spectrum Disorder.

Authors:  Stephane Kremer; Felix Renard; Sophie Achard; Marco A Lana-Peixoto; Jacqueline Palace; Nasrin Asgari; Eric C Klawiter; Silvia N Tenembaum; Brenda Banwell; Benjamin M Greenberg; Jeffrey L Bennett; Michael Levy; Pablo Villoslada; Albert Saiz; Kazuo Fujihara; Koon Ho Chan; Sven Schippling; Friedemann Paul; Ho Jin Kim; Jerome de Seze; Jens T Wuerfel; Philippe Cabre; Romain Marignier; Thomas Tedder; Danielle van Pelt; Simon Broadley; Tanuja Chitnis; Dean Wingerchuk; Lekha Pandit; Maria Isabel Leite; Metha Apiwattanakul; Ingo Kleiter; Naraporn Prayoonwiwat; May Han; Kerstin Hellwig; Katja van Herle; Gareth John; D Craig Hooper; Ichiro Nakashima; Douglas Sato; Michael R Yeaman; Emmanuelle Waubant; Scott Zamvil; Olaf Stüve; Orhan Aktas; Terry J Smith; Anu Jacob; Kevin O'Connor
Journal:  JAMA Neurol       Date:  2015-07       Impact factor: 18.302

6.  Imaging the visual pathway in neuromyelitis optica.

Authors:  Caspar F Pfueller; Friedemann Paul
Journal:  Mult Scler Int       Date:  2011-03-16

7.  White matter atrophy and cognitive dysfunctions in neuromyelitis optica.

Authors:  Frederic Blanc; Vincent Noblet; Barbara Jung; François Rousseau; Felix Renard; Bertrand Bourre; Nadine Longato; Nadjette Cremel; Laure Di Bitonto; Catherine Kleitz; Nicolas Collongues; Jack Foucher; Stephane Kremer; Jean-Paul Armspach; Jerome de Seze
Journal:  PLoS One       Date:  2012-04-03       Impact factor: 3.240

8.  Quantitative Susceptibility Mapping Indicates a Disturbed Brain Iron Homeostasis in Neuromyelitis Optica - A Pilot Study.

Authors:  Thomas Martin Doring; Vanessa Granado; Fernanda Rueda; Andreas Deistung; Juergen R Reichenbach; Gustavo Tukamoto; Emerson Leandro Gasparetto; Ferdinand Schweser
Journal:  PLoS One       Date:  2016-05-12       Impact factor: 3.240

9.  Quantitative 7T MRI does not detect occult brain damage in neuromyelitis optica.

Authors:  Baptiste Pasquier; Nadja Borisow; Ludwig Rasche; Judith Bellmann-Strobl; Klemens Ruprecht; Thoralf Niendorf; Tobias J Derfuss; Jens Wuerfel; Friedemann Paul; Tim Sinnecker
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2019-03-07

10.  Diffuse white matter damage is absent in neuromyelitis optica.

Authors:  F Aboul-Enein; M Krssák; R Höftberger; D Prayer; W Kristoferitsch
Journal:  AJNR Am J Neuroradiol       Date:  2009-09-12       Impact factor: 4.966

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.